VERBIO Vereinigte BioEnergie AG

  • WKN: A0JL9W
  • ISIN: DE000A0JL9W6
  • Land: Deutschland

Nachricht vom 04.06.2019 | 14:07

VERBIO Vereinigte BioEnergie AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

VERBIO Vereinigte BioEnergie AG

04.06.2019 / 14:07
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Notification of Major Holdings

1. Details of issuer
Name: VERBIO Vereinigte BioEnergie AG
Street: Ritterstraße 23 (Oelßners Hof)
Postal code: 04109
City: Leipzig
Germany
Legal Entity Identifier (LEI): 529900W51PINCFFALS96

2. Reason for notification
  Acquisition/disposal of shares with voting rights
  Acquisition/disposal of instruments
  Change of breakdown of voting rights
X Other reason:
Execution of conditional purchase contract

3. Details of person subject to the notification obligation
Natural person (first name, surname): Albertina Sauter
Date of birth: 13 Jul 1939
Natural person (first name, surname): Alois Fridolin Sauter
Date of birth: 20 Jun 1939

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
Claus Sauter, Bernd Sauter, Daniela Sauter, Marion Sauter, Pollert Holding GmbH & Co. KG

5. Date on which threshold was crossed or reached:
03 Jun 2019

6. Total positions
  % of voting rights attached to shares
(total of 7.a.)
% of voting rights through instruments
(total of 7.b.1 + 7.b.2)
Total of both in %
(7.a. + 7.b.)
Total number of voting rights pursuant to Sec. 41 WpHG
New 68.80 % 0.00 % 68.80 % 63000000
Previous notification 68.80 % 7.94 % 68.80 % /

7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN Absolute In %
  Direct
(Sec. 33 WpHG)
Indirect
(Sec. 34 WpHG)
Direct
(Sec. 33 WpHG)
Indirect
(Sec. 34 WpHG)
DE000A0JL9W6 5819181 37526000 9.24 % 59.56 %
Total 43345181 68.80 %

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
%
    Total %

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
%
      Total %

8. Information in relation to the person subject to the notification obligation
X Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
  Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more)
 

9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)

Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:
Proportion of voting rights Proportion of instruments Total of both
% % %

10. Other explanatory remarks:
Persons subject to the reporting obligation live in joint property. The spouses are each solely entitled to dispose with regard to voting rights. 

Date
04 Jun 2019



04.06.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC-Fokusbox

Expedeon AG mit attraktiver Produktpipeline

Durch die konsequente Fortsetzung der „Grow, Buy & Build“-Strategie hat die im Bereich der Entwicklung und Vermarktung von DNA-Technologien, Proteomik- und Antikörper-Konjugations-Anwendungen tätige Expedeon AG das Umsatzniveau angehoben und auf operativer Ergebnisebene zugleich den Break-Even nachhaltig überschritten. Für die kommenden Perioden ist der Ausbau der Umsatzerlöse mit den bestehenden Produkten geplant. Darüber hinaus verfügt die Expedeon AG über eine attraktive Produktpipeline mit hohem Umsatzpotenzial. Unser Kursziel liegt bei 3,20 € je Aktie. Das Rating lautet KAUFEN.

News im Fokus

Wirecard AG: Statement zum Artikel der Financial Times

16. Oktober 2019, 09:01

Aktuelle Research-Studie

Original-Research: GBC Insider Focus Index (von GBC AG): GBC Insider Focus Index

16. Oktober 2019